Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Incidence rate of type 1 diabetes significantly increased after COVID-19 infection
Read More »Accelerated Progression to T1D During Pandemic Seen for Presymptomatic Youth
Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes
Quarterly out-of-pocket costs increased by approximately $23 on average after age 65 years
Read More »Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2D
No significant increase seen with use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries
Read More »Certain Diets May Protect Against Heart Disease With Type 1 Diabetes
Higher adherence tied to lower inflammatory marker levels over time
Read More »Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk
Metformin displayed lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had highest risk
Read More »Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later
Nonadherence likely owed to mix of side effects such as nausea and vomiting and out-of-pocket costs
Read More »New Report Calls for More Research on Women’s Health Issues
By Robin Foster HealthDay ReporterFRIDAY, July 12, 2024 (HealthDay News) — A new report finds research is sorely lacking on how chronic illnesses affect women, and it urged government agencies to do more to investigate how these diseases strike women differently.The National Academies of Sciences, Engineering and Medicine analysis, commissioned …
Read More »GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D
Risk reduced for 10 of 13 obesity-associated cancers with GLP-1 RA use versus insulin in individuals with type 2 diabetes
Read More »Testosterone Tied to Incidence, Progression of Metabolic Syndrome
Estradiol associated with reduced metabolic syndrome risk and testosterone associated with increased risk in both cisgender, transgender individuals
Read More »Delaying Diabetes Progression After Impaired Glucose Improves Long-Term Outcomes
Significant risk reduction for death and vascular complications seen with maintaining at least four years of nondiabetes
Read More »